Activity not yet confirmed Verified 7 Nov 2026
i&i Bio
Prague-based early-stage life sciences venture fund, linked to the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, investing in drug discovery, medtech, diagnostics and AI startups mainly in Central and Eastern Europe.
- Type
- VC firm
- Location
- Prague, Czech Republic
- Stages
- Pre-seed, Seed, Series A
- Sectors
- Healthtech and life sciences, Biotech, Medtech, AI
- Fund size / AUM
- EUR 53M (own site meta description)
- Website
- www.inibio.eu
Contacts on file
For i&i Bio, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked); check size; LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
HeartBeat.bioCaptain T CellT-CURXCeleris TherapeuticsDracen Pharmaceuticals
Sources
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 28 lists
Medtech investors in Europe (45)Biotech investors in Europe (89)Series A medtech investors (125)Pre-seed medtech investors (129)Pre-seed biotech investors (148)Series A biotech investors (153)AI investors in Europe (230)Pre-seed investors in Europe (260)Seed medtech investors (278)Healthtech investors in Europe (291)Seed biotech investors (300)Series A investors in Europe (329)Series A healthtech investors (401)Pre-seed healthtech investors (408)Venture capital firms in Europe (412)Medtech investors (457)Biotech investors (484)Series A AI investors (500)Seed investors in Europe (543)Pre-seed AI investors (633)Startup investors in Europe (725)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Seed AI investors (1,082)Healthtech investors (1,207)AI investors (1,576)Seed investors (1,892)